CDK9 and in situ carcinoma: Our data revealed that TAK-243 significantly reduced the levels of K48 polyUB induced by both LAP (Fig. 5c) and CIS (Supplementary Fig. S5b), while simultaneously leading to an increase in protein aggregation.